Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Heart Failure in the Cardio-Renal-Metabolic Patient: Front-Line Decisions
Author(s): Debasish Banerjee Added: 2 weeks ago
Prof Debasish Banerjee (St George's University Hospitals NHS Foundation Trust, London, UK) joins us to discuss the practical management of heart failure in patients with coexisting chronic kidney disease (CKD) and diabetes, and how to close the gap between guideline recommendations and everyday clinical practice.In this interview, Prof Banerjee addresses one of the central challenges in cardio… View more

Cardiovascular Kidney Metabolic

Heart Failure
Research Area(s) / Expertise:
Dr Richard Schatz is research director of cardiovascular interventions at the Scripps Heart, Lung, and Vascular Center and director of gene and stem cell therapy. A recognized international expert in interventional cardiology, he has published and lectured extensively. His seminal work in coronary stents spurred a revolution in the treatment of coronary artery disease – more than 2 million of… View more
Managing Obesity in HF: 2025 ACC Scientific Statement
Author(s): Michelle Kittleson Added: 11 months ago
In this short interview, we are joined by Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) to discuss the key updates and recommendations from the 2025 ACC Scientific Statement on the Management of Obesity in Adults with Heart Failure.Interview Questions:1. What is the current research landscape for heart failure patients with obesity?2. What are the new recommendations in this scientific… View more

Cardiovascular Kidney Metabolic

Heart Failure
Research Area(s) / Expertise:
Prof Ewa Jankowska is Professor of Medicine and Head of Laboratory of Applied Research on Cardiovascular System at the Department of Heart Diseases, Wroclaw Medical University, Poland. Her clinical and research interests include the role of peripheral mechanisms in the progression of heart failure, co-morbidities in heart failure, and experimental model of tachycardia-induced cardiomyopathy. … View more
Job title: Advocate for Obesity; EPCO Secretary
Susie Birney lives with a food disorder called ARFID; she understands that there is not only one cause for obesity and not one treatment which will always work. Type 2 Diabetes and other co-morbidities have been health barriers for her since her 30’s. Since 2016, Susie has been a patient representative with the ASOI and an Irish representative with ECPO. This led to the start of creating a… View more
Research Area(s) / Expertise: Job title: Professor of Cardiology and Consultant Cardiologist
Prof Stephan von Haehling is aProfessor of Cardiology and Consultant Cardiologist atUniversity Medicine Göttingen, Göttingen, DE. His PhD was awarded by Imperial College, London, UK after he completed studies on inflammatory mechanisms of heart failure at the National Heart and Lung Institute in London. Prof von Haehling is a Fellow of the European Society of Cardiology and of the Heart… View more
Aarti Asnani
Research Area(s) / Expertise: Job title: MD
Dr Asnani is Associate Director and an attending physician in the Cardio-Oncology Program at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts and is an active researcher in the field. She joined BIDMC in 2017 and prior to this worked at the Massachusetts General Hospital. She earned her medical degree at the Duke School of Medicine, Durham, North Carolina in 2008, one of the… View more
Darryl Leong
Job title: Associate Professor
Dr Darryl Leong is Director of the Cardio-Oncology Program at Hamilton Health Sciences, and an Associate Professor of the Department of Medicine at McMaster University. He graduated from the University of Adelaide Medical School with honors for academic excellence, and completed his training in Cardiology, Doctor of Philosophy, Master of philosophy, Master of Biostatistics and Master of Public… View more
Delayed ATTR-CM Diagnosis Common in HF Patients
Added: 4 months ago Source:  Radcliffe Cardiology
A new study has revealed significant delays in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) following an initial diagnosis of heart failure (HF), with the median time to diagnosis exceeding one year.¹ Timely identification of ATTR-CM is critical to reduce morbidity and mortality, as effective treatments are available.²MethodologyThis retrospective cohort study analysed data… View more

Heart Failure